Overall, the assay demonstrated acceptable variability to warrant further invivotesting.
2
These asymmetries are normally observed during invivotesting.
3
If a correspondence were to be found, this would enable experimental use of the C6 tumor model for invivotesting of chemotherapeutic agents.
4
The number of possible combinations of chemicals is innumerable, and invivotesting of these mixtures is unattainable from an ethical, economical, or pragmatic perspective.
5
Invivotesting of 3a and miltefosine against C. albicans in a mouse model of systemic infection did not demonstrate efficacy.
6
Invivotesting of designed scaffolds showed that they could support bone regeneration via delivery of BMP-7 transduced human gingival fibroblasts in a mouse model.